Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 4, 2010, Pages 421-427

  Caja, Sergio ^a   Myrsky, Essi ^a   Korponay Szabo, Ilma R ^b,c   Nadalutti, Cristina ^a   Sulic, Ana Marija ^d   Lavric, Miha ^d   Sblattero, Daniele ^e   Marzari, Roberto ^d   Collighan, Russell ^f   Mongeot, Alexandre ^g   Griffin, Martin ^f   Mäki, Markku ^a,h   Kaukinen, Katri ^a,h   Lindfors, Katri ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d UNIVERSITY OF TRIESTE   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f ASTON UNIVERSITY   (United Kingdom)

^g X Link   (United Kingdom)

^h TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Autoantibodies; Coeliac disease; Transglutaminase 2 activity

Indexed keywords

AUTOANTIBODY; ENZYME INHIBITOR; MONOCLONAL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 INHIBITOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELIAC DISEASE; CELL CULTURE; CONTROLLED STUDY; CROSS LINKING; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SERUM;

ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; BIOPSY; BLOTTING, WESTERN; CELIAC DISEASE; CELL CULTURE TECHNIQUES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP-BINDING PROTEINS; HUMANS; IMMUNOGLOBULIN A; NEOVASCULARIZATION, PATHOLOGIC; TRANSGLUTAMINASES;

EID: 77949903860     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365520903540822     Document Type: Article

References (27)

1. Cooke WT, Holmes GKT. Coeliac disease. London: Churchill Livingstone; 1984. p. 27-28
2. Myrsky E, Syrjanen M, Korponay-Szabo IR, Maki M, Kaukinen K, Lindfors K. Altered small-bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol 2009;44:168-171
3. Marzari R, Sblattero D, Florian F, Tongiorgi E, Not T, Tommasini A, et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001;166:4170-4176
4. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3: 797-801
5. Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 2006;13:1442-1453
6. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J 1999;13:1787-1795
7. Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004;53:641-648
8. Salmi TT, Collin P, Korponay-Szabo IR, Laurila K, Partanen J, Huhtala H, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal auto antibody deposits. Gut 2006;55:1746-1753
9. Kaukinen K, Peräaho M, Collin P, Partanen J, Woolley N, Kaartinen T, et al. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005;40:564-572
10. Myrsky E, Kaukinen K, Syrjanen M, Korponay-Szabo IR, Maki M, Lindfors K. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin Exp Immunol 2008;152:111-119
11. Di Niro R, Ziller F, Florian F, Crovella S, Stebel M, Bestagno M, et al. Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol 2007;7:46
12. Piacentini M, Fesus L, Sartori C, Ceru MP. Retinoic acidinduced modulation of rat liver transglutaminase and total polyamines in vivo. Biochem J 1988;253:33-38
13. Piacentini M, Ceru MP, Dini L, Di Rao M, Piredda L, Thomazy V, et al. In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid. Biochim Biophys Acta 1992;1135:171-179
14. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL, Melino E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 1992;52: 271-278
15. Abramoff M, Magelhaes P, Ram S. Image processing with ImageJ. Biophotonics Int 2004;11:36-42
16. Griffin M, Mongeot A, Collighan R, Saint RE, Jones RA, Coutts IG, et al. Synthesis of potent water-soluble tissue transglutaminase inhibitors. Bioorg Med Chem Lett 2008;18:5559-5562
17. Myrsky E, Caja S, Simon-Vecsei Z, Korponay-Szabo IR, Nadalutti C, Collighan R, et al. Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA. Cell Mol Life Sci 2009;66: 3375-3385
18. Kiraly R, Vecsei Z, Demenyi T, Korponay-Szabo IR, Fesus L. Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness. J Autoimmun 2006;26:278-287
19. Dieterich W, Trapp D, Esslinger B, LeidenbergerM, Piper J, Hahn E, et al. Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity. Gut 2003;52:1562-1566
20. Esposito C, Paparo F, Caputo I, Rossi M, Maglio M, Sblattero D, et al. Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. Gut 2002;51:177-181
21. Antonyak MA, Singh US, Lee DA, Boehm JE, Combs C, Zgola MM, et al. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem 2001;276:33582-33587
22. Tucholski J, Lesort M, Johnson GV. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience 2001;102: 481-491
23. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 2003;278:391-399
24. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJ, et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994;4: 6584-6596
25. Oliverio S, Amendola A, Rodolfo C, Spinedi A, Piacentini M. Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J Biol Chem 1999;274:34123-34128
26. Shin DM, Jeon JH, Kim CW, Cho SY, Kwon JC, Lee HJ, et al. Cell type-specific activation of intracellular transglutaminase 2 by oxidative stress or ultraviolet irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem 2004;279:15032-15039
27. Currò M, Condello S, Caccamo D, Ferlazzo N, Parisi G, Ientile R. Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells. Amino Acids 2009;36:725-730